Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MST1R | Q04912 | 16/20 | 0.52 |
| ▸ | MET | P08581 | 4/20 | 0.52 |
| ▸ | AXL | P30530 | 2/20 | 0.52 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.52 |
| ▸ | MERTK | Q12866 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2285562 | 0.93 | MST1R (0.54) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL2280609 | 0.91 | MST1R (0.49) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL2280897 | 0.89 | MET (0.54) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL4730364 | 0.85 | AXL (0.56) | METAXLTYRO3MERTK | |
| SCHEMBL2282337 | 0.80 | MET (0.56) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL12376921 | 0.79 | MST1R (0.58) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL14205651 | 0.79 | MET (0.43) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL2282430 | 0.78 | AXL (0.57) | MST1RMETAXLTYRO3MERTK | |
| SCHEMBL2281518 | 0.77 | MST1R (0.56) | MST1RMET | |
| SCHEMBL2282816 | 0.77 | AXL (0.54) | METAXLTYRO3MERTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1989211-A2 | HETEROBICYCLIC THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER | Array Biopharma, Inc. (US) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008063202-A2 | HETEROBICYCLIC THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER | ARRAY BIOPHARMA INC. (US) | 2008-05-29 | — | — | WO | disclosed |